Form 4: Edgewell Personal Care CEO Acquires Restricted Stock Equivalents

Edgewell Personal Care's CEO, Rod R. Little, acquired 51,853 restricted stock equivalents on November 8, 2024, which will vest over the next three years.

Summary

• Rod R. Little, the CEO of Edgewell Personal Care, acquired 51,853 restricted stock equivalents (RSEs) on November 8, 2024.
• These RSEs will vest and convert into shares of Edgewell common stock in three equal installments on November 8, 2025, November 8, 2026, and November 8, 2027, provided Mr. Little remains employed by the company on those dates.
• The vesting of the RSEs may also occur upon death, disability, change in control, or certain termination events.
• The transaction was reported on November 12, 2024.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. There are no negative implications.

Positives

• The acquisition of RSEs by the CEO aligns his interests with the long-term performance of the company.
• The vesting schedule encourages continued service and commitment from the CEO.

Risks

• The vesting of the RSEs is contingent on continued employment, which could be a risk if the CEO were to leave the company before the vesting dates.

Future Outlook

The restricted stock equivalents will vest over the next three years, contingent on the CEO's continued employment.

Industry Context

The granting of restricted stock equivalents is a common practice in executive compensation, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Many companies, such as Procter & Gamble (PG) and Unilever (UL), use similar equity-based compensation plans for their executives.
• The vesting schedule of three years is also a common practice to ensure long-term commitment from executives.
• The specific terms of the RSEs, such as vesting upon change of control, are also standard in executive compensation packages.

Stakeholder Impact

• The vesting of RSEs could potentially increase the number of shares outstanding, which may have a minor dilutive effect on existing shareholders.
• The long-term vesting schedule encourages the CEO to focus on the company's long-term performance, which is beneficial for shareholders.

Key Dates

Keywords

restricted stock equivalents, RSE, Edgewell Personal Care, Rod R. Little, CEO, equity compensation, vesting